Influenza vaccine uptake in adults aged 50-64 years: Policy and practice in England 2003/2004

被引:6
作者
Joseph, C
Elgohari, S
Nichols, T
Verlander, N
机构
[1] Hlth Protect Agcy Ctr Infect, Resp Dis Dept, London NW9 5EQ, England
[2] Hlth Protect Agcy Ctr Infect, State Modelling & Econ Dept, London NW9 5EQ, England
关键词
influenza; immunisation; vaccine uptake;
D O I
10.1016/j.vaccine.2005.10.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A small national study was carried out in England in 2003/2004 to ascertain the views of primary care trusts (PCTs) and general practitioners (GPs) on whether influenza immunisation should be extended to all people aged 50-64 years from the current recommendation of 65 years or more. Results showed that as many primary care trusts would be in favour, as would not be in favour. A similarly divided view was expressed by general practitioners. Vaccine uptake rates for high-risk (HR) and low-risk (LR) adults aged 50-64 years in the study population were higher in those practices where the GP was in favour of a more inclusive policy of offering flu vaccine to all persons aged 50 years or more, compared with those that did not favour this policy (60% versus 54% HR (p = 0.02) and 16% versus 11% LR (p = 0.02)). Higher rates of vaccine uptake for low-risk patients aged 50-64 years were also reported from practices where GPs perceived a greater health benefit of immunisation for this age group. Although policy for recommending vaccine to all patients aged 50 years or more is established elsewhere, opinion on whether such a policy should be adopted in England is currently divided amongst those providing local health services. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1786 / 1791
页数:6
相关论文
共 50 条
[31]   Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age [J].
Gorse, Geoffrey J. ;
Falsey, Ann R. ;
Fling, John A. ;
Poling, Terry L. ;
Strout, Cynthia B. ;
Tsang, Peter H. .
VACCINE, 2013, 31 (19) :2358-2365
[32]   The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age [J].
Moehling, Krissy K. ;
Nowalk, Mary Patricia ;
Lin, Chyongchiou Jeng ;
Bertolet, Marnie ;
Ross, Ted M. ;
Carter, Chalise E. ;
Susick, Michael ;
Saul, Sean G. ;
Kaynar, A. Murat ;
Bromberger, Joyce T. ;
Zimmerman, Richard K. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) :361-367
[33]   Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial [J].
Grant, Lauren ;
Whitaker, Jennifer A. ;
Yoon, Sarang K. ;
Lutrick, Karen ;
Bhargava, Shivam ;
Brown, C. Perry ;
Zaragoza, Emily ;
Fink, Rebecca V. ;
Meece, Jennifer ;
Wielgosz, Kristina ;
El Sahly, Hana ;
Hegmann, Kurt T. ;
Lowe, Ashley A. ;
Southworth, Alia ;
Tatum, Tanya ;
Ball, Sarah W. ;
Levine, Min Z. ;
Thiese, Matthew S. ;
Battan-Wraith, Steph ;
Barnes, John ;
Phillips, Andrew L. ;
Fry, Alicia M. ;
Dawood, Fatimah S. .
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (10)
[34]   Understanding the Global Burden of Influenza in Adults Aged 18-64 years: A Systematic Literature Review from 2012 to 2022 [J].
Maleki, Farzaneh ;
Welch, Verna ;
Lopez, Santiago M. C. ;
Cane, Alejandro ;
Langer, Jakob ;
Enstone, Ashley ;
Markus, Kristen ;
Wright, Olivia ;
Hewitt, Nicole ;
Whittle, Isabelle .
ADVANCES IN THERAPY, 2023, 40 (10) :4166-4188
[35]   Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004 [J].
Shuler, Carrie M. ;
Iwamoto, Martha ;
Bridges, Carolyn Buxton ;
Marin, Mona ;
Neeman, Ruth ;
Gargiullo, Paul ;
Yoder, Terrace A. ;
Keyserling, Harry L. ;
Terebuh, Pauline D. .
PEDIATRICS, 2007, 119 (03) :E587-E595
[36]   Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses [J].
Ritzwoller, DP ;
Bridges, CB ;
Shetterly, S ;
Yamasaki, K ;
Kolczak, M ;
France, EK .
PEDIATRICS, 2005, 116 (01) :153-159
[37]   Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort study [J].
Loiacono, Matthew M. ;
Mahmud, Salaheddin M. ;
Chit, Ayman ;
van Aalst, Robertus ;
Kwong, Jeffrey C. ;
Mitsakakis, Nicholas ;
Skinner, Luke ;
Thommes, Edward ;
Bricout, Helene ;
Grootendorst, Paul .
VACCINE: X, 2020, 4
[38]   Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17 [J].
Tessier, E. ;
Warburton, F. ;
Tsang, C. ;
Rafeeq, S. ;
Boddington, N. ;
Sinnathamby, M. ;
Pebody, R. .
VACCINE, 2018, 36 (23) :3231-3238
[39]   A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older [J].
Essink, Brandon J. ;
Vermeulen, Wim ;
Andrade, Coralie ;
de Rooij, Richard ;
Isakov, Leah ;
Casula, Daniela ;
Albano, Frank R. .
VACCINE, 2025, 51
[40]   Influenza vaccine coverage among healthy children and adolescents aged 0-18 years from outpatient clinics in Warsaw in 2004-2010 [J].
Nitsch-Osuch, Aneta ;
Money, Edyta Ilona ;
Topczewska-Cabanek, Agnieszka ;
Zycinska, Katarzyna ;
Wardyn, Kazimierz A. .
FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2012, 14 (02) :198-201